🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
336

Quick answer

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Sildenafil

    United Therapeutics Europe Ltd

    Scleroderma

    phase 2 small molecule active

    1 trial

  2. Sildenafil Citrate

    United Therapeutics Europe Ltd

    Edema, Pulmonary

    phase 2 small molecule completed

    1 trial

  3. Siltuximab

    United Therapeutics Europe Ltd

    Schwannomatosis

    phase 2 small molecule active

    1 trial

  4. Sorafenib

    United Therapeutics Europe Ltd

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  5. Splinting

    United Therapeutics Europe Ltd

    Hand Osteoarthritis

    phase 2 other completed

    1 trial

  6. Stellate Ganglion Block injection with ropivicane

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder (PTSD)

    phase 2 other completed

    1 trial

  7. Steroids switch

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  8. Sutent®/Sunitinib

    United Therapeutics Europe Ltd

    Neurofibromatosis

    phase 2 small molecule terminated

    1 trial

  9. TERBINAFINE HYDROCHLORIDE (1%)

    United Therapeutics Europe Ltd

    Tinea Pedis

    phase 2 small molecule active

    1 trial

  10. TRC105

    United Therapeutics Europe Ltd

    Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial

  11. Taxotere

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  12. Tecovirimat

    United Therapeutics Europe Ltd

    Smallpox

    phase 2 small molecule active

    1 trial

  13. Telehealth Intervention

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 2 other active

    1 trial

  14. Tenofovir gel

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 small molecule completed

    1 trial

  15. Teriparatide

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule completed

    1 trial

  16. Tesamorelin 2 Milligrams (MG)

    United Therapeutics Europe Ltd

    Peripheral Nerve Injuries

    phase 2 small molecule active

    1 trial

  17. Testosterone Gel applied by a pump

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial

  18. Testosterone cypionate

    United Therapeutics Europe Ltd

    Castration Resistant Metastatic Prostate Cancer

    phase 2 small molecule completed

    1 trial

  19. Thyroplasty

    United Therapeutics Europe Ltd

    Vocal Cord Paralysis Unilateral

    phase 2 other completed

    1 trial

  20. Tibolone

    United Therapeutics Europe Ltd

    Menopause

    phase 2 small molecule completed

    1 trial

  21. Tocilizumab

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule completed

    1 trial

  22. Traditional fabricated prosthetic socket

    United Therapeutics Europe Ltd

    Amputation

    phase 2 other completed

    1 trial

  23. Tranexamic Acid

    United Therapeutics Europe Ltd

    Hemorrhage

    phase 2 small molecule completed

    1 trial

  24. Tranexamic Acid

    United Therapeutics Europe Ltd

    Anterior Cruciate Ligament Reconstruction

    phase 2 small molecule active

    1 trial

  25. Trastuzumab

    United Therapeutics Europe Ltd

    Metastatic Colorectal Adenocarcinoma

    phase 2 small molecule completed

    1 trial

  26. Trastuzumab

    United Therapeutics Europe Ltd

    Metastatic Colon Adenocarcinoma

    phase 2 mab terminated

    1 trial

  27. Treprostinil

    United Therapeutics Europe Ltd

    Ischemia Reperfusion Injury

    phase 2 small molecule active

    1 trial

  28. Treprostinil Inhalation Solution

    United Therapeutics Europe Ltd

    Respiratory Distress Syndrome, Adult

    phase 2 small molecule terminated

    1 trial

  29. Trientine

    United Therapeutics Europe Ltd

    Hypertrophic Cardiomyopathy

    phase 2 small molecule completed

    1 trial

  30. UB-221

    United Therapeutics Europe Ltd

    Chronic Spontaneous Urticaria

    phase 2 mab active

    1 trial

  31. UB-311

    United Therapeutics Europe Ltd

    Alzheimer's Disease

    phase 2 mab terminated

    3 trials

  32. UB-421(25 mg/kg) Q2W

    United Therapeutics Europe Ltd

    HIV-1 Infection

    phase 2 mab completed

    1 trial

  33. UB-612

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 mab completed

    4 trials

  34. UB-621

    United Therapeutics Europe Ltd

    Genital Herpes

    phase 2 mab active

    1 trial

  35. UBT251

    United Therapeutics Europe Ltd

    Obesity &Amp; Overweight

    phase 2 small molecule active

    1 trial

  36. UBT251

    United Therapeutics Europe Ltd

    Metabolic Dysfunction-associated Steatohepatitis (MASH)

    phase 2 small molecule active

    1 trial

  37. UBT251 Injection 2.0 mg and UBT251 Injection Placebo

    United Therapeutics Europe Ltd

    Obesity &Amp; Overweight

    phase 2 small molecule completed

    1 trial

  38. UBT251 Injection 2.0 mg and UBT251 Injection Placebo

    United Therapeutics Europe Ltd

    Type 2 Diabetes Mellitus (T2DM)

    phase 2 small molecule completed

    1 trial

  39. UT-15C

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  40. VLA2001

    United Therapeutics Europe Ltd

    SARS-CoV-2 Virus Infection

    phase 2 mab completed

    1 trial

  41. VMP001

    United Therapeutics Europe Ltd

    Malaria

    phase 2 mab completed

    1 trial

  42. VRC-HIVDNA016-00-VP

    United Therapeutics Europe Ltd

    HIV Infections

    phase 2 mab completed

    1 trial

  43. Valaciclovir/Aciclovir

    United Therapeutics Europe Ltd

    Critical Illness

    phase 2 small molecule completed

    1 trial

  44. Valproic Acid

    United Therapeutics Europe Ltd

    Retinitis Pigmentosa

    phase 2 small molecule completed

    1 trial

  45. Valproic Acid

    United Therapeutics Europe Ltd

    Pain, Phantom

    phase 2 small molecule completed

    1 trial

  46. Valproic Acid Solution

    United Therapeutics Europe Ltd

    Acute Kidney Injury

    phase 2 small molecule terminated

    1 trial

  47. Vasopressin

    United Therapeutics Europe Ltd

    Traumatic Shock

    phase 2 small molecule completed

    1 trial

  48. Vinflunine

    United Therapeutics Europe Ltd

    Locally-advanced or Metastatic Penile Neoplasms

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.